scispace - formally typeset
Search or ask a question

What are the potential applications of mesenchymal stem cells in regenerative medicine? 

Best insight from top research papers

Mesenchymal stem cells (MSCs) have potential applications in regenerative medicine. MSCs can be easily obtained from various sources such as bone marrow, adipose tissue, and umbilical cord. They have the ability to differentiate into different cell types, including chondrocytes, osteocytes, and adipocytes, making them suitable for tissue repair . MSCs and their secreted exosomes have unique advantages, including immunomodulatory effects, lack of immunogenicity, and recruitment to damaged areas. MSCs also have the ability to self-renew and differentiate, while exosomes have been shown to have therapeutic potential . In veterinary medicine, MSCs have been used to treat various conditions in dogs and cats, such as orthopedic conditions, kidney disease, and inflammatory bowel disease . MSCs have also shown promise in the treatment of refractory and recurrent diseases, including hematological diseases, neurological diseases, and immune diseases . In the field of central nervous system regeneration, MSCs have been studied for their potential in promoting immunomodulation, anti-apoptosis, and axon re-extension .

Answers from top 5 papers

More filters
Papers (5)Insight
The potential applications of mesenchymal stem cells in regenerative medicine include central nervous system regeneration, spinal cord injury, cerebral ischemia, and neurodegenerative diseases.
The potential applications of mesenchymal stem cells in regenerative medicine include treatment of hematological diseases, wound healing, digestive diseases, neurological diseases, endocrine diseases, immune diseases, movement diseases, and urogenital diseases.
The potential applications of mesenchymal stem cells in regenerative medicine include treating orthopaedic conditions in dogs and various diseases in cats such as asthma, kidney disease, chronic gingivostomatitis, and inflammatory bowel disease.
The potential applications of mesenchymal stem cells in regenerative medicine include tissue repair, treating defects and diseases, and recent advances in clinical trials.
The paper discusses the potential applications of mesenchymal stem cells (MSCs) in regenerative medicine, including their use in replacing damaged cells, tissues, or organs.

Related Questions

What are the potential applications of bone marrow stem cells in regenerative medicine?4 answersBone marrow stem cells have potential applications in regenerative medicine for tissue repair and regeneration. These stem cells can be mobilized or homed to the site of injury, contributing to tissue regeneration. They have been shown to have therapeutic effects in various diseases and conditions, including hematological diseases, wound healing, digestive diseases, neurological diseases, endocrine diseases, immune diseases, movement diseases, and urogenital diseases. In the field of bone healing and regeneration, bone marrow-derived stem cells have been used in combination with biomaterials and bioactive substances to promote bone repair and regrowth. They have the potential to differentiate into osteoblasts and have paracrine properties that aid in tissue repair. In veterinary species, mesenchymal stem cells derived from bone marrow have been studied for their potential in enhancing bone regeneration when combined with scaffolds.
What are the potential applications of identifying and manipulating the osteogenic differentiation of mesenchymal cells in regenerative medicine?5 answersThe identification and manipulation of osteogenic differentiation in mesenchymal cells have potential applications in regenerative medicine. Mesenchymal stem cells (MSCs) have the ability to differentiate into various cell types, including osteoblasts, which are crucial for bone regeneration. By understanding the molecular mechanisms involved in osteogenic differentiation, such as the role of microRNAs (miRNAs) in regulating gene expression, researchers can manipulate these processes to enhance bone formation. For example, miR-4699 has been identified as a direct suppressor of genes involved in osteoblast differentiation, and its overexpression promotes osteoblast mineralization and marker gene expression. Additionally, the use of exosomes secreted by MSCs has shown promise in regenerative medicine, as they possess immunomodulatory effects and can be recruited to damaged areas. Furthermore, the identification of marker genes, such as IGF1 and SRGN, can help predict the osteogenic differentiation potential of MSCs, aiding in the selection of competent cells for regenerative therapies. Overall, understanding and manipulating osteogenic differentiation in mesenchymal cells can contribute to the development of effective regenerative medicine strategies for bone defects.
What are Mesenchymal stem cell?5 answersMesenchymal stem cells (MSCs) are multipotent stromal cells that have the ability to differentiate into various cell types, including adipocytes, osteocytes, and chondrocytes. They can be isolated from various human and animal tissues and are characterized by their high proliferative capacity and differentiation in the connective-tissue direction. MSCs also exhibit paracrine and trophic activity, producing a wide range of biologically active molecules. These cells have been shown to have therapeutic potential in experimental models and clinical trials, making them a promising alternative for traditional treatment methods. MSCs have been studied for their potential in treating a variety of diseases, including immune and musculoskeletal system disorders, cardiovascular disease, and neurological diseases. They have been found to promote tissue repair and regeneration through their paracrine functions, reducing inflammation, promoting neovascularization, and enhancing endogenous neurogenesis. Additionally, MSCs have immunomodulatory effects and can migrate to the site of organ and tissue damage.
How are stem cells used in regenerative medicine?4 answersStem cells are used in regenerative medicine to replace damaged cells and tissues and to treat various diseases and conditions. They have the ability to differentiate into different cell types and can be guided to become specific cells that can regenerate and repair damaged tissues. Stem cell-based regenerative medicine has progressed to clinical testing and therapeutic applications, with adult stem cells from adipose tissue showing promise in treating autoimmune and neurodegenerative diseases, vascular and metabolic diseases, and bone and cartilage regeneration. Additionally, stem cells have the potential to be grown into new tissue for transplant and regenerative medicine. In the field of pediatric cardiology, stem cells are being studied for the engineering of pediatric heart valves, which could be a breakthrough in treating congenital heart defects. Overall, stem cells offer unprecedented opportunities for developing new medical therapies and have the potential to revolutionize regenerative medicine.
What are the clinical applications of mesenchymal stem cell-derived extracellular vesicles?4 answersMesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have various clinical applications. They have potential therapeutic applications in ischemic diseases and regenerative medicine by accelerating angiogenesis. MSC-EVs can reverse the condition of polycystic ovary syndrome (PCOS) and improve fertility. They also play a role in regulating programmed cell death (PCD) in different diseases, including inflammation-associated PCD. Preconditioning MSCs with trophoblast stem cell-derived EVs enhances their proliferation and regenerative capacity, making them suitable for MSC-based therapeutic applications. MSC-EVs can be used as drug delivery vehicles in cancer therapy, promoting or inhibiting tumor growth and delivering therapeutic molecules. Overall, MSC-EVs have potential in treating various diseases and conditions, including ischemic diseases, PCOS, inflammation-associated PCD, and cancer therapy.
What are the future applications of regenerative medicine?4 answersRegenerative medicine holds great promise for the future with various applications. One potential application is the development of methods to regrow, repair, or replace damaged or diseased cells, organs, or tissues. This includes the creation of functional human organs outside the body using three-dimensional bioprinting, which can support living human tissues and be personalized for therapeutic applications. Tissue engineering technologies such as 3D printing and organoids-on-a-chip offer versatile and predictive preclinical models that can reduce the dependency on animal models and aid in drug discovery. Additionally, regenerative medicine can be applied at the cellular, tissue, and organ levels, utilizing human pluripotent stem cells for disease modeling and regenerative applications. The use of cellular therapies, extracellular vesicles, and tissue-engineered constructs are also being investigated for personalized, patient-specific treatments in regenerative medicine. Overall, regenerative medicine has the potential to revolutionize healthcare by providing innovative solutions for organ replacement, tissue repair, and disease treatment.

See what other people are reading

How effective are stem cell therapies in treating collapsed trachea in dogs, and what are the potential side effects?
5 answers
Stem cell therapies, specifically Stem cells from human exfoliated deciduous teeth (SHED), have shown promise in treating tracheal fistulas in rats, accelerating fistula healing and reducing lung inflammation. In dogs with collapsing trachea, endoluminal stent placement has provided a high survival rate, even for severe cases, with improvements in clinical signs like dyspnea and raspy breathing. Tracheal and airway collapse in dogs can lead to chronic cough and airway obstruction, with bronchomalacia being common in older dogs, necessitating correct identification and appropriate medical or surgical intervention. Potential side effects of endoluminal stent placement in dogs include complications like stent fracture and tissue ingrowth, which may require additional procedures.
What treatments for spinal cord injuries are currently being investigated?
4 answers
Current research on treatments for spinal cord injuries (SCI) includes the investigation of various regenerative strategies. Mesenchymal stem cells (MSCs) show promise in SCI treatment due to their regenerative capabilities, such as neuroprotection, neuronal regeneration, and immunomodulation. Biomaterial scaffolds combined with stem cell therapy aim to facilitate cell-material interactions and neuroprotection, advancing novel therapeutic strategies from bench to bedside. Cell-based therapies, including the use of Schwann cells, olfactory ensheathing cells, and different types of stem cells, have been studied in clinical trials, showing potential for neurological and functional recovery in SCI patients. Additionally, experimental treatments like the combined use of tetrahedral framework nucleic acid with neural stem cells and Fortasyn® Connect supplementation have demonstrated significant improvements in functional recovery and attenuation of secondary injury processes, highlighting their neuroregenerative and neuroprotective properties.
What is the future of tracheal graft?
5 answers
The future of tracheal grafts lies in advancing tissue engineering techniques to promote revascularization and enhance graft survival. Challenges such as insufficient revascularization, tissue necrosis, and lumen stenosis need to be addressed for long-term success. Strategies like using vascular endothelial growth factor (VEGF) and immunosuppression have shown promise in enhancing graft revascularization and viability. Additionally, the colonization of decellularized tracheal tissues by adult nasal chondrocytes has demonstrated the potential for producing new cartilage tissue suitable for tracheal repair. Studies have shown that partially decellularized tracheal grafts can support neovascularization and endothelial cell regeneration, highlighting the potential for future advancements in tracheal graft technology. Overall, the future of tracheal grafts involves refining techniques to improve revascularization, reduce complications, and enhance long-term graft survival.
What are the leading research focus areas for biotechnology?
5 answers
The leading research focus areas in biotechnology include the development of various products with therapeutic applications, such as DNA-derived biopharmaceuticals for treating diseases. Additionally, the field of biotechnology is advancing in areas like environmental biotechnology, focusing on biofuels, greenhouse gas reduction, and hazardous waste treatment, as well as medical biotechnology, which aims to cure diseases like Alzheimer's, Parkinson's, and spinal cord injuries. Recent research themes in biotechnology encompass metabolic engineering, utilizing organisms like Escherichia coli and Saccharomyces cerevisiae for biosynthesis of beneficial biomolecules such as vitamins, monoterpenes, and acids. Nanoparticles and nanotechnology are also emerging as significant research themes within the biotechnology field, indicating a continuous evolution and innovation in this area.
How can keratinocytes and C. acnes be co-cultured?
5 answers
Keratinocytes and C. acnes can be co-cultured to study interactions relevant to skin health. Studies have shown that co-culturing keratinocytes with C. acnes can lead to the activation of toll-like receptors (TLRs) 2 and 4 in keratinocytes, inducing innate immune and inflammatory responses. This co-culture model can mimic the interactions occurring in conditions like acne, where C. acnes plays a role in inflammatory acne lesions. Additionally, co-culturing keratinocytes and sebocytes, another major cell type in the pilosebaceous unit, can provide a more accurate representation of acne physiology compared to culturing either cell type alone. By utilizing co-culture models, researchers can assess inflammatory cytokine production and neutral lipid content in response to acne etiologic stimulants, aiding in understanding acne pathogenesis and screening potential treatments.
What are the current approved drugs for acute lung injury treatment?
4 answers
Currently approved drugs for acute lung injury (ALI) treatment include Cepharanthine (CEP) dry powder inhalers (DPIs) for anti-inflammatory effects, nonselective phosphodiesterase inhibitors like xanthines and selective PDE inhibitors (PDE3, PDE4, PDE5) that stabilize the pulmonary barrier and reduce inflammation, and human amnion-derived mesenchymal stem cells (hAMSCs) that alleviate alveolar-capillary permeability and oxidative stress, possibly through NF-κB pathway inhibition. Additionally, gene therapy using non-viral vectors such as lipids, dendrimers, and exosomes is being explored for ALI treatment, focusing on enhancing alveolar fluid clearance and suppressing inflammation. Furthermore, memantine, an NMDAR antagonist, has shown promise in inhibiting macrophage Nlrp3 inflammasome activation and pyroptosis, thereby alleviating ALI in septic mice.
Why do adult tooth don’t grow back when fallen?
5 answers
Adult teeth do not grow back when fallen due to the limited rate of tooth movement, higher risk of iatrogenic root resorption and pulp devitalisation, and lack of growth potential in adults. Regenerative dentistry offers potential solutions through methods like mesenchymal stem cell transplantation, biomimetic scaffold manipulation, and growth factor control to improve orthodontic treatment outcomes in adult patients. Additionally, regenerative endodontics aims to revitalize teeth and induce root maturation using mesenchymal stem cells, growth factors, and scaffolds, showing promising results in both immature and mature necrotic teeth. The psychological significance of tooth loss in adults is also highlighted, with dreams symbolizing fear of growing old through tooth loss, reflecting concerns about aging and personal discontent.
What is the influence of cryopreservation for adipose-derived stem cells?
5 answers
Cryopreservation plays a crucial role in maintaining the viability and functionality of adipose-derived stem cells (ASCs) for various applications. Studies have focused on optimizing cryopreservation protocols, investigating the effects of different cryoprotective agents like DMSO and trehalose, and exploring the impact of cryopreservation conditions on downstream cellular activities. Efficient control of cryopreservation parameters is essential to ensure reproducible mass-manufacturing compliant protocols and minimize phenotypic/functional changes in ASCs. Cryopreservation allows for the long-term storage of ASCs, enabling a ready off-the-shelf source of viable therapeutic doses for tissue engineering and regenerative medicine applications. By understanding the mechanisms involved in cryopreservation and its effects on ASCs, researchers aim to enhance the preservation of stemness characteristics and differentiation potentials of these valuable cells.
What is the current state of research on the distribution and function of mesenchymal cells in Latin America?
5 answers
Research on mesenchymal cells in Latin America is multifaceted. Studies highlight the therapeutic potential of Medicinal Signaling Cells (MSCs) in treating various diseases. Furthermore, investigations focus on the use of bone marrow mesenchymal cells (MSCs) for Chagas disease therapy, emphasizing their immune modulatory properties and potential in chagasic cardiomyopathy treatment. Latin American countries like Brazil and Argentina have regulations overseeing cell-based treatments, while Mexico lacks recognition for cell therapies, creating a disparity in the region. Stem cell research in Latin America receives funding primarily from government and institutional grants, with studies covering a wide range of areas from clinical to scientific aspects, showcasing the region's diverse contributions to the field. Overall, Latin America is actively engaged in exploring the distribution and therapeutic functions of mesenchymal cells, contributing significantly to global research efforts.
What is the role of mesenchymal stem cells in Klebsiella pneumoniae infections?
5 answers
Mesenchymal stem cells (MSCs) play a crucial role in Klebsiella pneumoniae infections by modulating the host immune response and enhancing therapeutic outcomes. Studies have shown that MSC administration, whether naïve or pre-activated, can attenuate Klebsiella-induced pneumonia by improving lung function, reducing bacterial load, and enhancing tissue repair. MSCs have been found to accelerate epithelial healing, increase phagocytosis, and reduce lung injury in pre-clinical models of Klebsiella pneumosepsis. Furthermore, MSC therapy has been shown to modulate immune cell profiles, reduce inflammatory responses, and enhance bacterial clearance, ultimately improving survival rates in Klebsiella pneumoniae-infected mice. Overall, MSCs demonstrate promising immunomodulatory, antibacterial, and therapeutic potential in combating Klebsiella pneumoniae infections.
What are the current advancements in understanding and manipulating mesenchymal cells for therapeutic purposes?
5 answers
Recent advancements in manipulating mesenchymal stem cells (MSCs) for therapeutic purposes involve various strategies to enhance their potency and functionality. These include priming MSCs with soluble factors or pharmacologic agents, genetic and epigenetic modifications, and utilizing physical methods like 3D culture systems. MSCs have shown a dual role in cancers, being able to promote or inhibit tumor growth, and can also serve as carriers for anticancer agents. Challenges such as poor migration, low survival rates, and donor-dependent variations have led to the exploration of approaches to improve the clinical outcomes of MSC-based therapies. Understanding the interactions between MSCs and the host, their immunomodulatory potential, and regenerative capabilities are key areas of focus for developing effective cell-based therapies.